Liposcience Inc (LPDX) financial statements (2022 and earlier)

Company profile

Business Address 2500 SUMNER BOULEVARD
RALEIGH, NC 27616
State of Incorp. DE
Fiscal Year End December 31
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments49,574
Cash and cash equivalents49,574
Receivables5,821
Inventory, net of allowances, customer advances and progress billings224
Inventory224
Other undisclosed current assets972
Total current assets:56,591
Noncurrent Assets
Property, plant and equipment13,955
Intangible assets, net (including goodwill)841
Intangible assets, net (excluding goodwill)841
Restricted cash and investments502
Deferred costs64
Other noncurrent assets45
Total noncurrent assets:15,407
TOTAL ASSETS:71,998
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,045
Accounts payable2,045
Other undisclosed current liabilities19,560
Total current liabilities:21,605
Noncurrent Liabilities
Liabilities, other than long-term debt2,635
Other liabilities2,635
Total noncurrent liabilities:2,635
Total liabilities:24,240
Stockholders' equity
Stockholders' equity attributable to parent47,758
Common stock15
Additional paid in capital108,271
Accumulated deficit(60,528)
Total stockholders' equity:47,758
TOTAL LIABILITIES AND EQUITY:71,998

Income statement (P&L) ($ in thousands)

12/31/2013
Revenues
(Revenue, Net)
52,383
Cost of revenue
(Cost of Goods and Services Sold)
(12,042)
Other undisclosed gross profit1,300
Gross profit:41,641
Operating expenses(52,321)
Operating loss:(10,680)
Nonoperating income87
Investment income, nonoperating93
Interest and debt expense(1,942)
Net loss available to common stockholders, diluted:(12,535)

Comprehensive Income ($ in thousands)

12/31/2013
Net loss:(12,535)
Comprehensive loss, net of tax, attributable to parent:(12,535)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: